ALIZABETHE WHIPPLE, FNP-C
Family Nurse Practitioner · AUSTIN, TX
Individual Active NPI 1295365286
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 536 | 163,429 | $13,860,007 | $4,148,612 | $3,297,480 |
| 2023 | 272 | 104,127 | $8,381,000 | $2,111,321 | $1,676,559 |
| 2022 | 329 | 70,574 | $7,012,348 | $1,783,070 | $1,416,828 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 39,480 | $11 | $8 |
| J0897 | Injection, denosumab, 1 mg | 10,980 | $26 | $21 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 7,560 | $18 | $14 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 6,600 | $19 | $15 |
| J2357 | Injection, omalizumab, 5 mg | 4,515 | $37 | $29 |
| J2182 | Injection, mepolizumab, 1 mg | 3,700 | $30 | $24 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,420 | $31 | $25 |
| J3245 | Injection, tildrakizumab, 1 mg | 1,800 | $136 | $108 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 1,487 | $0 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 798 | $12 | $9 |
| J3489 | Injection, zoledronic acid, 1 mg | 430 | $6 | $5 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 286 | $50 | $38 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | AP144614 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Texas
- NPI 1508783036
- NPI 1093479487
- NPI 1922597699
- NPI 1528524857
- NPI 1518377498
- NPI 1578926440
- NPI 1134842321
- NPI 1992053797
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.